Interestingly, the expression of these genes was predicted to be mostly controlled by the transcription factor TP53 (Fig. 4E), whose activation contributes to the neurodegenerative processes associated with ALS [33, 34]. The gene discussed is TP53; the disease is amyotrophic lateral sclerosis.